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Objective: to identify salient behavioral, normative, control and self-efficacy beliefs related to 
the behavior of adherence to oral antidiabetic agents, using the Theory of Planned Behavior. 
Method: cross-sectional, exploratory study with 17 diabetic patients in chronic use of oral 
antidiabetic medication and in outpatient follow-up. Individual interviews were recorded, 
transcribed and content-analyzed using pre-established categories. Results: behavioral 
beliefs concerning advantages and disadvantages of adhering to medication emerged, such 
as the possibility of avoiding complications from diabetes, preventing or delaying the use of 
insulin, and a perception of side effects. The children of patients and physicians are seen as 
important social references who influence medication adherence. The factors that facilitate 
adherence include access to free-of-cost medication and taking medications associated with 
temporal markers. On the other hand, a complex therapeutic regimen was considered a factor 
that hinders adherence. Understanding how to use medication and forgetfulness impact the 
perception of patients regarding their ability to adhere to oral antidiabetic agents. Conclusion: 
medication adherence is a complex behavior permeated by behavioral, normative, control and 
self-efficacy beliefs that should be taken into account when assessing determinants of behavior.
Descriptors: Medication Adherence; Behavior; Diabetes Mellitus; Nursing.
Beliefs related to adherence to oral antidiabetic treatment
according to the Theory of Planned Behavior1
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Introduction
The use of non-pharmacological and pharmacological 
treatment is recommended to control and facilitate the 
management of Diabetes Mellitus (DM). Hence, special 
attention has been paid to factors related to medication 
adherence, since patients with chronic diseases, the 
emergence of which are asymptomatic, are more likely 
not to adhere to medication(1). It is known that despite 
considerable technological advancements achieved in 
regard to the diagnosis and treatment of DM patients, 
a large number of people do not adhere to their 
recommended treatment(2-3).
In general, medication adherence is seen as a 
measure in which patients follow instructions for the 
treatments prescribed(4). The decision to take medication 
or not is an empirical-rational strategy patients use to 
express their attempts to deal with the disease.  It is 
important to acknowledge and not to underestimate 
the patients’ decision-making abilities, identifying their 
beliefs and helping them adopt appropriate behaviors.
The Theory of Planned Behavior (TPB)(5), one of the 
main models used to study health-related behaviors, 
assumes that beliefs impact predictive factors of intention 
(motivation) – immediate mediator of behavior. Hence, 
identifying beliefs regarding medication adherence is 
key to understanding patients’ self-care actions because 
beliefs represent the opinions of patients, based on 
their knowledge or experiences, in regard to health 
orientation, influencing acceptance or rejection of the 
prescribed therapy(6).
Even though TPB is widely used in studies seeking 
understanding various health behaviors, its application 
in studies addressing behaviors related to the prevention 
and/or control of DM is incipient. Among DM patients, 
there are studies addressing regular exercise(7), insulin 
administration(8), intake of low saturated-fat foods(9), 
and adherence to oral antidiabetic agents(10), however, 
no studies have been conducted with a Brazilian 
population with DM.
This study’s aim was to identify and analyze 
salient beliefs – behavioral, normative, control and 
self-efficacy, related to adherence to oral antidiabetic 
agents through the application of TPB. Identifying these 
beliefs using TPB is an essential step to support the 
development of a measurement instrument to identify 
factors that determine adherence to oral antidiabetic 
agents. Understanding these determinants can aid 
the development of effective interventions to promote 
adherence to these medications.
Method
Cross-sectional, exploratory study with a qualitative 
and quantitative approach guided by the TPB theoretical 
framework.
Theoretical framework
This motivational model was derived from 
cognitive-social theories in which behavior is 
determined by intention (motivation) to act (effectively 
perform a given behavior) and by one’s perception 
of control over behavior. Intention, the immediate 
antecedent of behavior, is determined by three factors: 
Attitude – an individual’s assessment in regard to 
the probable or expected outcomes of a behavior; 
Subjective Norm – perceived social pressure, that is, the 
individual’s perception concerning the opinion of social 
references in regard to a given behavior; and Perceived 
Behavioral Control – the individual’s perception in 
regard to his/her control over behavior(5,11). Each 
of the three determinants of Intention is formed by 
their respective beliefs. Behavioral beliefs refer to 
the assessment of results of behavior and produce a 
favorable or unfavorable attitude toward it. Normative 
beliefs refer to the perception of social references 
concerning a given behavior and result in a subjective 
norm. Control beliefs are created with the presence 
of perceived factors that may either facilitate or 
hinder a given behavior and influence perceived 
behavioral control(5,11). The model recommends that, 
when identifying beliefs, salient beliefs, i.e., those 
that come first to mind when an interviewee is asked 
open questions about behavior, should be taken 
into account(12).
Even though the literature indicates the strong 
predictive power of TPB in determining behavioral 
intention in regard to a complex range of behaviors, 
researchers(13) have defended the inclusion of other 
variables as being able to improve the explanation of 
variability of motivation and its predictive power for 
behavior. The selection of these variables depends on 
their relevance to understanding a desired behavior 
and the characteristics of the studied behavior. In 
regard to medication adherence, the variable Self-
efficacy was considered relevant and refers to an 
individual’s confidence in his/her ability to perform 
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Study setting
This study was conducted in a general adult 
outpatient clinic of a large university hospital in the 
interior of the state of São Paulo.
Subjects
Individuals 18 years old or older, with diagnosis 
of type 2 DM, under chronic use of oral antidiabetic 
medications for at least six months, monitored by 
the aforementioned clinic, participated in the study. 
Individuals whose administration of medication was 
managed by a caregiver, who used insulin, had been 
hospitalized or undergone surgery in the last 30 days, 
or showed impaired understanding or communication 
abilities, were excluded. A convenience sample 
was used. All the patients who met the inclusion 
criteria were consecutively added into the study 
until data saturation was achieved, i.e., when no 
new information was obtained and reports became 
redundant(15).
Data collection
Data were obtained from March to April 2012 
through individual semi-structured interviews, under 
a free-response format intended to identify salient 
beliefs(11). The interviews were conducted and recorded 
in a private environment and later transcribed verbatim.
Instruments
- Socio-demographic and clinical characterization: 
composed of socio-demographic data (age, sex, 
schooling, work status, and family income) and clinical 
data (length of diagnosis, number of medications, and 
classes of antidiabetic agents being used);
- Self-reported measurement of medication adherence, 
according to two criteria(2) – 1) Proportion of 
adherence: assessed through four frameworks that 
describe: 1. Name, dose and posology of the prescribed 
medication; 2. How each medication was taken in the 
24 hours prior to the interview; 3. How medication was 
taken in the prior week; and 4. How medication was 
taken in the prior month. Tables 2 and 3, concerning 
medication intake for the day and week before, are 
intended to obtain more accurate responses through 
minimizing memory bias. Adherence to oral antidiabetic 
medications was calculated based on the doses omitted 
in the last month as reported by the patient according 
to the following formula [(prescribed doses – missed 
doses) x 100 / prescribed doses](16). For those taking 
more than one oral antidiabetic agent, the final 
proportion was computed by the mean of adherence 
percentages for each medication. The proportion 
of adherence was assessed as a continuous variable 
(mean of medication taken) and a categorical variable, 
classified into the appropriate number of doses (≥80% 
of the prescribed) and an insufficient number of doses 
(<80%); 2) Global assessment of adherence considers, 
in addition to the proportion of doses taken, the way 
medications were taken, the frequency, and care 
required for their administration, while considering 
association with temporal markers: fasting, breakfast, 
lunch, dinner and bedtime. The patients were classified 
into the groups: I – Number of doses and care 
appropriate to prescription; II – Appropriate number of 
doses and inadequate care; III – Insufficient number 
of doses and appropriate care; and IV – Inappropriate 
number of doses and care. The patients classified 
into Group I were considered to be adherent to 
medication treatment and those classified into Groups 
II, III and IV were considered non-adherent to their 
medication regimens.
- Elicitation of beliefs concerning adherence to oral 
antidiabetic agents: developed according to the 
TPB(11) assumptions and submitted to content validity 
by five judges who are experts in behavioral studies, 
in the application of the TPB, and in the construction 
and validation of measurement instruments(17). The 
instrument is composed of 17 open and semi-open 
questions distributed into general beliefs concerning 
behavior (one), salient behavioral beliefs (three), 
normative (five), control (six) and self-efficacy beliefs 
(two). Behavior was defined as: “to take medication 
for diabetes treatment exactly as prescribed by my 
physician over the next two months”, which includes 
target, action, context and time, in accordance with the 
TPB(11) premises.
Data analysis
The answers were submitted to content analysis 
based on the recommendations of the TBP theoretical 
model(11,18). The following stages were followed: 
i) exploration of material in order to categorize it using 
categories pre-established by TPB, i.e., behavioral, 
normative, control and self-efficacy beliefs concerning 
adherence to oral antidiabetic medication; ii) the 
answers were grouped into each category according 
to themes or subcategories that were extracted 
from the participants’ reports. The subcategories 
that emerged from the reports were submitted 
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to inter-observer analysis to ensure reliability of 
assessment (two researchers who were experts in 
the application of TPB), with an agreement level of 
95% between the judges, and iii) the frequency 
of subcategories were calculated and modal/more 
frequent beliefs were highlighted. To identify which 
beliefs would be included, we used one of the criteria 
proposed by TPB, in which beliefs that exceed a 
given frequency are considered modal. All the beliefs 
mentioned in this study by at least 10% of the sample 
were included. 
Table 1 - Sociodemographic and clinical characterization of patients with Diabetes Mellitus in outpatient follow-up by 
a university hospital (N=17). Campinas, SP, Brazil, 2012
*Minimum Wage (MW) current in April 2012 = R$ 622.00 (equivalent to USD 339.89)
Ethical aspects
The Project was approved by the Institutional 
Review Board at a university in the interior of São Paulo, 
Brazil (Process No. 6.608/2012).
Results
The sample was composed of 17 individuals, most 
of whom were women (64.7%), aged 59.8 years old on 
average, with 3.9 years of schooling on average, and 
lived with other people (88.2%). Family income was 2.5 
times the minimum wage on average (Table 1).
Variable n % Average (SD) Median Observed variation
Sociodemographic
Age (years) 59.8 (13.9) 57 40-84
Schooling (years) 3.9 (3.3) 4 0-11
Monthly family income (MW)* 2.5 (2.0) 1.9 1-8





Length of DM diagnosis (months) 68.6 (62.1) 48 8-240
Number of classes of medication in use 6.8 (2.8) 7 3-13
Oral antidiabetic agents in use
Metformin 8 47.1
Sulfonylurea 2 11.8
Metformin + Sulfonylurea 7 41.2
Adherence proportion (%) 83.7 (25.7) 95 0-100
Use ≥80% of the prescribed doses 12 70.6
Global assessment of adherence
Adherent 9 53.0
Nonadherent 8 47.0
In regard to the prescription of oral antidiabetic 
agents, we verified the prescription of Metformin only 
(47.1%) or in association with Sulfonylurea (41.2%). 
The patients reported they took 83.7% of the prescribed 
doses in the prior months to the interview and most 
(52.9%) were considered adherent in the global 
adherence assessment.
Considering behavioral beliefs concerning 
adherence to oral antidiabetic agents, seven analytical 
subcategories emerged, representing the advantages 
and disadvantages of behavior of adhere to oral 
antidiabetic medication (Table 2). Disadvantages 
were mentioned in most of the reports, especially the 
medications’ side effects (82.4%), followed by the 
hypoglycemic symptoms attributed to the medications 
(29.4%), as shown in the following reports: It’s not 
normal to have loose bowels so often. You may get dehydrated 
(Subject 16). Sometimes I get all sweaty, my tongue tingles. So 
I have to eat something salty or sweet. This always happens to 
me. It gets out of control. So, I guess it’s because of the chronic 
use of medication (Subject 16).
Advantages included having the disease and 
glycemia under control, which were mentioned in 
58.8% of the reports, and preventing complications, 
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Table 2 - Behavioral beliefs concerning the behavior of adhere to oral antidiabetic agents. Campinas, SP, Brazil, 2012
highlighted by 52.9% of the participants, as the 
following reports show: So, the medication controls sugar 
levels more than diet does. I’m not taking it these days and my 
sugar’s increasing (Subject 2); Now if I don’t take it, later on I 
may have complications. I’m afraid of developing complications, 
yes, because there was one case in my family and I had to 
take care of this person. And she didn’t take the medications 
(Subject 16). The prevention of negative outcomes such 
as death and hospitalization, or obtaining positive 
outcomes such as delaying treatment with insulin and 
hyperglycemic symptoms relief were less frequently 
mentioned. The following excerpts respectively reveal 
these beliefs: When my wife forgets, my daughters remind 
me. So I’m always reminded. They don’t want me hospitalized 
because of lack of medication (Subject 7); The physician said that 
if I responded well to this medication, I would not need insulin. 
So, I’d rather take the medication than insulin (Subject 13); 
It helps yes, it eases my diabetic symptoms. The burning 
sensation in my feet. I feel better. It doesn’t cure, but improves 
it (Subject 10).
Behavioral Beliefs %
To take medication for diabetes treatment exactly as prescribed by my physician...
It causes side effects 82.4
It keeps the glycemia and diabetes under control 58.8
It prevents diabetes complications 52.9
It prevents hospitalization and death 41.2
It avoids or delays the need for insulin 29.4
It causes hypoglycemic symptoms 29.4
It eases hyperglycemic symptoms 23.5
In regard to normative beliefs, the participants 
identified four groups of positive social references – their 
children, physicians, spouses, and the nursing staff, as 
shown in the reports: One of my children always helps me. If 
they don’t remind me, there’s no way I will remember. I always 
forget. My memory has failed for some time now. It’s more 
difficult (Subject 8); I follow the physicians’ recommendations, 
I trust them very much (Subject 7); He (points to the 
husband) helps me, he fetches it for me. Because the health 
unit is kind of far away and I have this pain in my legs, so he 
goes and fetches it for me. ‘Gimme the prescription’ he says 
(Subject 2). There’re the nurses from the diabetics meetings. 
They say: This diabetes thing kills, you know? You may have 
to have your leg cut out, you cannot get hurt (Subject 2). The 
presence of close family members (spouse, children) 
were considered favorable to adherence because 
they support the acquisition of medication, organize 
medications in appropriate containers, help the patient 
remember the times to take medications, and explain 
the therapeutic scheme to the patient.
The reports show that diabetic people who do not 
adhere to their medication treatment are referred to as 
negative social references: There is a cousin of my wife who 
says: “my grandmother had diabetes since her 30s, never took 
medication and died at the age of 90. Forget about it”. She says 
things like that and thinks I’m wrong because I’m forbidden of 
eating so many things. She thinks that I’m suffering for nothing, 
that, no, I don’t need to take it (Subject 7). These referents 
are those who experience complications due to DM, who 
do not adhere to their treatment, who report family 
problems, who do not care about their health, live by 
themselves, are either too old or too young, and most of 
all, do not believe in the treatment (Table 3). 
In regard to control beliefs, factors that either 
impeded/hindered or favored/facilitated behavior 
were reported and represent one and five categories, 
respectively. Among the five factors that facilitate 
are: the distribution of free-of-cost medication; 
having a routine and control of daily activities; taking 
medication associated with temporal markers; taking 
their medications with them whenever leaving home; 
and differentiating pills and tablets by color, form and 
size. The following reports reveal control beliefs: Getting 
the medications at the health unit helps…Some days you don’t 
have a coin to buy bread; I finish lunch and take the medication 
right after it, with a full stomach (Subject 17); Whenever I 
leave home, I take it with me. It’s a habit already. It’s like 
my wallet; I take it with me wherever I go out (Subject 7); 
I don’t know the name, but I recognize it by the color and 
size. Some are all the same (Subject 12); I have a schedule 
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Normative Beliefs %




The nursing staff 17.6
When taking medication for diabetes treatment exactly as prescribed, I would not be approved by…
Acquaintances who are diabetic and do not adhere to treatment 58.8
Table 3 - Normative beliefs concerning the behavior of adhere to oral antidiabetic agents. Campinas, SP, Brazil, 2012
Table 4 - Control beliefs related to the behavior of adhere to oral antidiabetic agents. Campinas, SP, Brazil, 2012
Table 5 - Self-efficacy beliefs concerning the behavior of adhere to oral antidiabetic agents. Campinas, SP, Brazil, 2012
Taking medications more than once a day hinders 
adherence to antidiabetic treatment: I have to take it in the 
morning and at night and this is what troubles me. It would be 
better if I had to take just once a day (Subject 10) (Table 4).
Control Beliefs %
These make it easier to take medication for diabetes treatment exactly as prescribed…
Access medication free-of-cost 70.6
Associate time of medication with temporal markers 29.4
Bring the pills whenever leaving home 29.4
Being able to differentiate pills by color, form and size 17.7
Having a routine and control over daily activities 11.8
This makes it harder to take medication for diabetes treatment exactly as prescribed…
Having to take medication more than once a day 23.5
Self-efficacy beliefs refer to the individual’s 
perception concerning his/her own ability to perform a 
given behavior. Analysis of this excerpt – The only thing 
I was talking about is that there were medications I was taking 
that I didn’t even know what they were for […] But, once I 
understand what they were for, things get easier (Subject 13) 
– reveals that the factor that enabled this individual 
to perform the behavior was understanding the 
prescription. A belief that explains a possible inability of 
an individual to adhere to oral antidiabetic medication is 
forgetfulness, as the following report shows: […] when I 
remember, you know? I work and take the medication with me. 
The problem is that I forget, I become involved with my work 
(Subject 14) (Table 5).
Self-efficacy beliefs %
I feel capable of taking medication for diabetes treatment exactly as prescribed due to...
Understanding the prescription and how the medication should be used 35.3
Sometimes I don’t feel capable of taking medications for diabetes treatment exactly as prescribed due to…
Forgetfulness 17.6
Discussion
This study’s aim was to elicit and analyze salient 
beliefs concerning adherence to oral antidiabetic agents 
through the application of TPB. This is a pioneering 
study in the Brazilian context, the findings of which can 
support the development of an instrument to measure 
the determinants of adherence to oral antidiabetic 
medication. According to TPB, each of the cognitive 
determinants of behavior consists of a set of beliefs 
and individuals’ assessment of such beliefs. Therefore, 
identifying the reasons behind the use of oral antidiabetic 
medication is key to understanding the determinants 
of medication adherence, as well as to supporting 
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the design of effective interventions to promote this 
behavior among DM patients(19). 
Health professionals face the challenge of 
discovering the cause of hyperglycemia when dealing 
with patients whose DM is poorly managed; that is, 
the professional has to determine whether the poor 
management is related to treatment nonadherence or 
occurs despite the correct use of medications. Since 
patients may be more willing to report their negative 
beliefs concerning medication treatment than admit 
to low adherence, asking for their beliefs may enable 
the identification of patients with a greater likelihood of 
nonadherence to treatment. 
In regard to behavioral beliefs, we highlight the 
impact of perceptions of reactions attributed to oral 
antidiabetic agents, which may lead to nonadherence. 
This result was also found in previous studies(19-20). 
Hypoglycemic episodes are also disadvantageous to 
adherence, responsible for irritation, sickness, and 
weakness, which contribute to the poor glycemic 
control of DM(21). Fear of these events increases stress 
associated with DM, with an important impact on the 
management of the disease and metabolic control(22). 
The advantages of adherence are related to controlling 
the disease, to minimizing complications, and 
preventing negative outcomes, which demonstrates 
the perception of DM as a progressive, potentially fatal, 
disease that culminates in treatment with insulin and 
impacts quality of life. A similar study(10) reports verbal 
accounts of a feeling of wellbeing that accrues from 
the regular use of oral antidiabetic medication, the 
potential reduction of complications, and maintaining 
control over glycemia and DM. 
In regard to normative beliefs, positive social 
referents included the patients’ children, physicians, 
spouses, and the nursing staff. Diabetic patients who do 
not adhere to the medication scheme were considered 
negative social referents. Health professionals should 
consider the influence of social references in the 
motivation of diabetic patients to adhere to treatment and 
propose interventions that promote positive referents. A 
previous study(23) using TPB in the identification of beliefs 
related to adherence to anti-retroviral therapy among 
seropositive Latin immigrants reports that family, spouse/
partner, physicians, and seropositive friends, in addition 
to the HIV/AIDS counselors and members of HIV support 
groups, were considered positive social references.
In regard to control beliefs, the factor that hindered 
or impeded medication adherence was the need to take 
medications more than once a day. It shows that the 
complexity of the therapeutic scheme is a factor that 
does not favor the correct use of medications. The 
factors that favored or facilitated adherence behavior 
were having access to free-of-cost medication, following 
a routine and having control over daily activities, taking 
medication associated with temporal markers, carrying 
medication when leaving home, and differentiating 
pills and tablets by color, form and size. Such items 
reveal that medication adherence is supported by 
ease of access to medication and by incorporation of 
medication into a daily routine, also a finding observed 
in previous studies(10,24).
Finally, positive beliefs in regard to self-efficacy 
in treatment adherence were: understanding the 
prescription and how the medication is used. The 
negative belief in this category was forgetfulness. 
These data corroborate findings in the literature(20-25). A 
similar study(19) identified most of the beliefs concerning 
DM medication adherence as being related to low 
adherence, highlighting the perception that there is no 
need to take medication when glycemia is under normal 
levels, concern over side effects, or due to complexity of 
the therapeutic scheme and dependence in following it. 
Conclusion
This study’s results show that adherence to oral 
antidiabetic agents is a complex behavior permeated by 
behavioral, normative, and control beliefs, which should 
be taken into account when assessing determinants of 
behavior. Behavioral beliefs concerning the perception 
of adverse reactions, hypoglycemia, the possibility of 
controlling glycemia and the disease, and prevention of 
negative outcomes emerged. Social references included 
the patients’ children, physicians, spouses, the nursing 
staff and other diabetic patients. Having access to 
free-of-cost medication, following a routine and having 
control of their daily life, taking medications associated 
with temporal markers, carrying medication whenever 
leaving home, and being able to differentiate pills by 
color, form and size facilitate adherence. On the other 
hand, having to take the medication more than once a 
day hinders adherence. Understanding the prescription 
undergirded the ability to perform the behavior while 
forgetfulness explained a possible inability to adhere 
to treatment.  Investigation concerning the influence 
of beliefs in regard to the intention to adhere to 
oral antidiabetic agents can support interventions 
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